Source / episode info
- **Episode:**194
- **Title:**Divine Intervention Episode 194 – Updated USMLE Step 1 Endocrine Review Series 3.
- **Published:**2019-12-22
- Source:Episode page
One-liner
This episode reviews high-yield endocrine topics including the classic presentation of Carcinoid Syndrome (flushing, diarrhea, right-sided heart disease), the distinct genetic mutations and clinical triads of MEN1/MEN2A/MEN2B syndromes, pituitary tumor management (prolactinoma vs. GH excess), and the diagnostic workup of Central versus Nephrogenic Diabetes Insipidus.
High-yield summary
- Carcinoid Syndrome: Caused by neuroendocrine tumors (often ileocolic) secreting excessive serotonin. Symptoms appear when metastases bypass hepatic first-pass metabolism (e.g., lungs, liver). Classic triad: Flushing, Diarrhea, Right-sided heart lesions (tricuspid insufficiency/pulmonary stenosis).
- MEN Syndromes: All are autosomal dominant and involve multiple endocrine glands. MEN1 involves Parathyroid adenomas, Pancreatic NETs (Gastrinoma, Insulinoma, Glucagonoma, VIPoma), and Pituitary tumors. MEN2A/B share Pheochromocytoma and Medullary Thyroid Cancer (MTC).
- Pituitary Tumors: Prolactinomas are treated primarily with dopamine agonists (e.g., cabergoline); GH-secreting adenomas require surgical resection first, followed by monitoring IGF-1 levels and performing a suppression test (e.g., 75g glucose load).
- Diabetes Insipidus (DI): Central DI results from ADH deficiency (hypothalamic/pituitary damage) and is diagnosed by low serum osmolality and failure to concentrate urine after water deprivation; Nephrogenic DI shows normal or high ADH levels.
- SIADH: Characterized by inappropriately concentrated urine in the setting of dilutional hyponatremia, often caused by CNS pathology (e.g., SCLC) or drugs (SSRIs, carbamazepine).
Learning objectives
- Differentiate the clinical presentations and underlying genetics of MEN1, MEN2A, and MEN2B syndromes.
- Recognize the classic triad associated with Carcinoid Syndrome and its metabolic consequences (Niacin deficiency).
- Master the diagnostic workup for Central vs. Nephrogenic Diabetes Insipidus using water deprivation testing and DDAVP challenge.
- Understand the differential diagnosis of pituitary tumors, differentiating between prolactinoma management (dopamine agonists) and GH excess (surgery/suppression test).
- Interpret electrolyte abnormalities in the context of polysecretory syndromes (e.g., hypercalcemia from MEN1/MEN2A; hypokalemia from VIPomas).
Board exam buzzwords